As a result, your skin can appear more radiant and even-looking
Best JH, Hoogwerf BJ, Herman WH, Pelletier EM, Smith DB, Wenten M, Hussein MA: Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database
Many patients experienced improvements in risk factors for heart disease, blood sugar levels, and quality of life
For more guidance on planning your fat loss cycle, check our peptide cycle planning guide
6
How clinicians read investigational obesity data When clinicians review early or mid-stage obesity data, they usually look at more than the headline weight-loss result